Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care Project

Journal of Urology

Volumn 180, Issue 2, 2008, Pages 520-524

  Huang, George J ^a   Hamilton, Ann S ^a   Lo, Mary ^a   Stein, John P ^a   Penson, David F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

bladder; carcinoma, transitional cell; quality of health care; SEER Program; standards

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; DEMOGRAPHY; DRUG USE; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADMINISTRATION, INTRAVESICAL; AGED; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 46449108161     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.04.016     Document Type: Article

References (19)

1. Baldwin L.M., Dobie S.A., Billingsley K., Cai Y., Wright G.E., Dominitz J.A., et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst 97 (2005) 12110
2. Bradley C.J., Given C.W., and Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94 (2002) 490
3. Krupski T.L., Kwan L., Afifi A.A., and Litwin M.S. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 23 (2005) 7881
4. Penson D.F. Variations in prostate cancer patterns of care: is it the quality of care or the quality of the data?. J Clin Oncol 23 (2005) 7783
5. Hodgson D.C., Fuchs C.S., and Ayanian J.Z. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93 (2001) 501
6. Smith Jr. J.A., Labasky R.F., Cockett A.T., Fracchia J.A., Montie J.E., and Rowland R.G. Bladder Cancer Clinical Guidelines Panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. J Urol 162 (1999) 1697
7. Scher H., Bahnson R., Cohen S., Eisenberger M., Herr H., Kozlowski J., et al. NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 12 (1998) 225
8. Hall M.C., Chang S.S., Dalbagni G., Pruthi R.S., Seigne J.D., Skinner E.C., et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178 (2007) 2314
9. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., Palou J., Algaba F., and Vicente-Rodriguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 164 (2000) 680
10. Morales A., Eidinger D., and Bruce A.W. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. 1976. J Urol 116 (1976) 180
11. O'Donnell M.A. Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer. Urol Clin North Am 32 (2005) 121
12. Witjes J.A. Bladder carcinoma in situ in 2003: state of the art. Eur Urol 45 (2004) 142
13. Konety B.R., Joyce G.F., and Wise M. Bladder and upper tract urothelial cancer. J Urol 177 (2007) 1636
14. Harlan L.C., Potosky A., Gilliland F.D., Hoffman R., Albertsen P.C., Hamilton A.S., et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 93 (2001) 1864
15. Greenberg E.R., Chute C.G., Stukel T., Baron J.A., Freeman D.H., Yates J., et al. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med 318 (1988) 612
16. Konety B.R., Dhawan V., Allareddy V., and Joslyn S.A. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the Surveillance, Epidemiology, and End Results Program. J Urol 173 (2005) 2085
17. Bach P.B., Cramer L.D., Warren J.L., and Begg C.B. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341 (1999) 1198
18. Potosky A.L., Harlan L.C., Kaplan R.S., Johnson K.A., and Lynch C.F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 (2002) 1192
19. Konety B.R., and Joslyn S.A. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170 (2003) 1765